PD06-10 SAFETY OF INTRADETRUSOR ONABOTULINUMTOXINA INJECTION IN THE ASYMPTOMATIC PATIENT WITH A POSITIVE URINE DIP

INTRODUCTION AND OBJECTIVES:According to the safety insert for usage of intradetrusor onabotulinumtoxinA (BTX-A) injection, a patient must not have a urinary tract infection (UTI) at the time of the procedure. In practice, many patients are tested with a point of care urine dipstick (UD) in the office before the procedure. Some surgeons may choose to inject in the setting of a positive UD if the patient is asymptomatic. We aim to evaluate differences in adverse events (AE) in asymptomatic patients with and without a positive UD at time of BTX-A injection.METHODS:Intradetrusor BTX-A injections were retrospectively reviewed between 2016-2018. Exclusion criteria included: indwelling catheter, recent urine culture, recent antibiotic course, or no UD on the day of injection. Patient demographic data and adverse events (AE) were extracted. Positive UD was defined as any combination of positive blood, leukocyte esterase (LE), or nitrite. Negative UD was defined as complete absence of any blood, LE, or nitrite. A...